China NMPA Product Recall - Interbody fusion device assistive tools

Zimmer Medical (Shanghai) International Medical Trading Co., Ltd., operating under the regulatory framework of the National Medical Products Administration (NMPA), initiated a voluntary Class II recall of specific Interbody Fusion Device Assistive Devices. This recall, publicly announced on December 7, 2016, addresses a critical safety concern related to the product's cleaning and decontamination. The main issue identified was that the existing cleaning and decontamination methods described in the instructions for use for the Fidji interbody fusion device assistive tools (encompassing various reamer models from 8-gauge to 14-gauge) were found to be inadequate. This deficiency presented a potential risk of incomplete sterilization, thereby increasing the risk of infection for patients. A total of 616 affected units were part of this global recall; however, it's important to note that no affected products were sold within China, and no domestic adverse events or complaints had been reported regarding this issue. In response, Zimmer Medical committed to several required actions: recalling the implicated products, issuing a comprehensive field safety notice to customers, updating the product's instructions for use to include validated and revised cleaning and decontamination protocols, and providing thorough training to relevant personnel on these updated procedures to mitigate future risks and ensure patient safety.